[Ip-health] Congressional Briefing: Improving Antimalarial Drug Quality in Africa

[James Love]

Why would the Congressional Malaria caucus give airtime to industry
shills like Roger Bate and Richard Tren?

  jamie

On Wed, 2008-06-04 at 12:50 -0400, Philip Coticelli wrote:
> --
> [ Picked text/plain from multipart/alternative ]
>   Africa Fighting Malaria in conjunction with the Congressional Malaria
> Caucus
> invites you to attend the Congressional briefing
> **
> *Improving Antimalarial Drug Quality in Africa*
> **
> Tuesday, June 10, 2008
> 10:00-11:30 am
> The Rayburn House Office Building
> Room 2200
> Washington DC
>
> A recent study published in PLoS ONE found approximately one third of
> antimalarial drugs sold in private pharmacies in six African countries were
> substandard or fake.  Numerous artemisinin monotherapy tablets were found on
> sale, despite being proscribed by the World Health Organization in 2006.
> Improving the quality of malaria treatment in Africa, where the majority of
> people access their medicines from the private sector, is vital.  Resistance
> to artemisinin therapies has already been found in South East Asia.  With no
> new class of drugs likely to replace artemisinin-based combination therapies
> for at least a decade, great care must be taken to control for the
> development of resistance.  Ensuring high quality combination therapies are
> used along with improved diagnosis is essential if the goals of the US
> President's Malaria Initiative are to be achieved and sustained.
> **
> *Speakers:*
> Dr. Roger Bate, Resident Fellow, American Enterprise Institute
> Dr. Bernard Nahlen, Deputy Coordinator, US President's Malaria Initiative
>
> *Moderator:*
> Richard Tren, Director, Africa Fighting Malaria
>
> Please RSVP to Kim Hess at khess@fightingmalaria.org
> _______________________________________________
> Ip-health mailing list
> Ip-health@lists.essential.org
> http://lists.essential.org/mailman/listinfo/ip-health
>